- Expression of hepatitis C virus nonstructural 4B in transgenic mice
-
Wang AG, Moon HB, Kim JM, Hwang SB, Yu DY, Lee DS
- KMID: 1094149
- Exp Mol Med.
- 2006 Jun;38(3):241-246.
Hepatitis C virus (HCV) is a pathogen that is of great medical significance in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Although the HCV proteins have been intensively investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: management of hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363030
- Clin Mol Hepatol.
- 2016 Mar;22(1):76-139.
- doi: 10.3350/cmh.2016.22.1.76
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: Management of Hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1788561
- Clin Mol Hepatol.
- 2014 Jun;20(2):89-136.
- doi: 10.3350/cmh.2014.20.2.89
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
-
Jeong SH
- KMID: 760731
- Korean J Hepatol.
- 2007 Sep;13(3):301-303.
- doi: 10.3350/kjhep.2007.13.3.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of Inosine Triphosphatase Variants on Hemoglobin Level and Sustained Virologic Response of Chronic Hepatitis C in Korean
-
Kim JS, Ahn SM, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1793028
- J Korean Med Sci.
- 2013 Aug;28(8):1213-1219.
- doi: 10.3346/jkms.2013.28.8.1213
Two variants of the inosine triphosphatase (ITPA: rs1127354, rs7270101) gene cause ITPA deficiency and protect against the hemolytic toxicity of ribavirin. We investigated the clinical significance of ITPA variants in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus and hepatocarcinogenesis
-
Jeong SW, Jang JY, Chung RT
- KMID: 1410890
- Clin Mol Hepatol.
- 2012 Dec;18(4):347-356.
- doi: 10.3350/cmh.2012.18.4.347
Hepatitis C virus (HCV) is an RNA virus that is unable to integrate into the host genome. However, its proteins interact with various host proteins and induce host responses. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Occult Hepatitis B Virus Infection in Chronic Hepatitis C
-
Jang JY, Park EJ
- KMID: 1707197
- Korean J Gastroenterol.
- 2013 Sep;62(3):154-159.
- doi: 10.4166/kjg.2013.62.3.154
Occult HBV infection is defined as the presence of HBV DNA in the liver (with or without detectable or undetectable HBV DNA in the serum) of individuals testing negative for... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C
-
Lee HJ, Eun JR, Choi JW, Kim KO, Moon HJ
- KMID: 1073329
- Korean J Hepatol.
- 2008 Mar;14(1):46-57.
- doi: 10.3350/kjhep.2008.14.1.46
BACKGROUND/AIMS: This study compared the efficacy and safety of combined peginterferon alfa (PEG-IFN) and ribavirin with that of combined interferon alpha (IFN-alpha) and ribavirin, according to the treatment duration... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus-induced hepatocellular carcinoma
-
Goossens N, Hoshida Y
- KMID: 2164359
- Clin Mol Hepatol.
- 2015 Jun;21(2):105-114.
- doi: 10.3350/cmh.2015.21.2.105
Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The interaction of HCV with its human host is complex and multilayered; stemming in part from the fact... -
- CITED
-
- Close
- SHARE
-
- Close
- A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection
-
Saad Y, Shaker O, Nassar Y, Ahmad L, Said M, Esmat G
- KMID: 2070084
- Gut Liver.
- 2014 Nov;8(6):655-661.
- doi: 10.5009/gnl13374
BACKGROUND/AIMS: A polymorphism in the microsomal triglyceride transfer protein (MTP) is associated with hepatic fibrosis, and carriers showed higher levels of steatosis, higher levels of hepatitis C virus (HCV) RNA... -
- CITED
-
- Close
- SHARE
-
- Close
- New Therapeutic Agent for Chronic Hepatitis C: Direct Acting Agent
-
Chae HB
- KMID: 2373305
- Korean J Gastroenterol.
- 2015 Jul;66(1):5-9.
- doi: 10.4166/kjg.2015.66.1.5
Peg-interferon and ribavirin has been the standard therapy of chronic hepatitis C for the past 15 years in Korea. However, the treatment paradigm is changing. Direct acting agents (DAAs) are... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Clinical Course of Hepatitis C Virus in Korea
-
Kwon JH, Bae SH
- KMID: 1767540
- Korean J Gastroenterol.
- 2008 Jun;51(6):360-367.
The mortality due to chronic liver disease, including liver cirrhosis and hepatocellular carcinoma (HCC), ranks as one of the highest in Korea. The prevalence rates of hepatitis C virus (HCV)... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of liver disease in Korea: Hepatitis C
-
Lim YS
- KMID: 853303
- Korean J Hepatol.
- 2009 Dec;15(Suppl 6):S25-S28.
- doi: 10.3350/kjhep.2009.15.S6.S25
Chronic hepatitis C (CHC) is the third most common cause of chronic liver disease and hepatocellular carcinoma (HCC) in Korea, following hepatitis B virus (HBV) infection and alcohol. HCV prevalence... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
-
Lee HS, Kweon YO, Tak WY, Park SY, Kang EJ, Lee YL, Yang HM, Park HW
- KMID: 1776802
- Clin Mol Hepatol.
- 2013 Jun;19(2):148-155.
- doi: 10.3350/cmh.2013.19.2.148
BACKGROUND/AIMS: Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Phospholipase D activity is elevated in hepatitis C virus core protein-transformed NIH3T3 mouse fibroblast cells
-
Kim J, Choi BH, Jang KL, Min DS
- KMID: 1123766
- Exp Mol Med.
- 2004 Oct;36(5):454-460.
Hepatitis C Virus (HCV) is associated with a severe liver disease and increased frequency in the development of hepatocellular carcinoma. Overexpression of HCV core protein is known to transform fibroblast... -
- CITED
-
- Close
- SHARE
-
- Close
- A case: control study on the risk factors of hepatitis C virus infection among Koreans
-
Kim YS, Ahn YO, Kim DW
- KMID: 932129
- J Korean Med Sci.
- 1996 Feb;11(1):38-43.
- doi: 10.3346/jkms.1996.11.1.38
In order to identify the risk factors for hepatitis C virus (HCV) infections, a case-control study was conducted from September 1993 to April 1994. HCV infection was confirmed by the... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus: virology and life cycle
-
Kim CW, Chang KM
- KMID: 1493570
- Clin Mol Hepatol.
- 2013 Mar;19(1):17-25.
- doi: 10.3350/cmh.2013.19.1.17
Hepatitis C virus (HCV) is a positive sense, single-stranded RNA virus in the Flaviviridae family. It causes acute hepatitis with a high propensity for chronic infection. Chronic HCV infection can... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of direct antiviral agent failures
-
Buti M, Esteban R
- KMID: 2373146
- Clin Mol Hepatol.
- 2016 Dec;22(4):432-438.
- doi: 10.3350/cmh.2016.0107
The current standard of care for patients with chronic hepatitis C virus (HCV) infection is a combination of direct-acting antiviral agents (DAAs). Most HCV patients treated with these drugs achieve... -
- CITED
-
- Close
- SHARE
-
- Close
- High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
-
Heo NY, Lim YS, Lee HC, Lee YS, Kim KM, Byun KS, Han KH, Lee KS, Paik SW, Yoon SK, Suh DJ
- KMID: 1493576
- Clin Mol Hepatol.
- 2013 Mar;19(1):60-69.
- doi: 10.3350/cmh.2013.19.1.60
BACKGROUND/AIMS: Identifying the impact of a patient's ethnicity on treatment responses in clinical practice may assist in providing individualized treatment regimens for chronic hepatitis C (CHC). The effectiveness of standard... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of ARCHITECT HCV Core Antigen Assay
-
Song D, Kang JE, Kim SY, Hwang SH, Kim HH, Lee EY, Son HC
- KMID: 1781673
- Korean J Lab Med.
- 2010 Dec;30(6):654-659.
- doi: 10.3343/kjlm.2010.30.6.654
BACKGROUND: Hepatitis C virus (HCV) core antigen (Ag) levels are known to be well correlating with HCV RNA levels, and may be used as an alternative marker of HCV replication... -
- CITED
-
- Close
- SHARE
-
- Close
